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Christie Hospital & Holt Radium Institute, Manchester M20 9BX Carcinomas arising from the alimentary tract account for 27% of recorded malignancies in the United Kingdom. The overall 5-year survival rate is 11% (Waterhouse 1974) . These depressing figures have not altered for a number of years, despite the introduction of cytotoxic agents (Philip 1978 , Priestman 1978 . Recently there have been a number of reports on the value of radiotherapy used with surgery for carcinoma of the rectum. One aspect of this problem has been investigated in a British trial (MRC 1974) . The scope and limitations of radiotherapy in this field depend very much on developments in surgical and radiotherapy practice. This paper reviews the natural history of gut carcinoma from the surgical point of view, emphasizing sites of tumour recurrence. Secondly, advances in radiotherapy technique are considered with reference to the pelvis and abdomen. Finally, some questions are posed which might be answered using formal clinical trials.
Surgery for gut carcinoma Early and advanced cases Until recently, an exploratory laparotomy was considered necessary for most carcinomas of the alimentary tract, not only to establish the diagnosis, but also to define the extent of the tumour and its suitability for resection. As a result, tumours fall into three categories. In the first group liver metastases are found at laparotomy, or are considered a contraindication to laparotomy. Radiotherapy has not generally been offered to these patients if they have no symptoms, since control of the primary tumour will not affect survival appreciably. A second group have extensive tumours which are technically unresectable because of involvement of adjacent organs. Again, radiotherapy has not been used since the immediate and long-term effects of large field radiotherapy to the abdomen were considered hazardous. A third group have a tumour which seems technically resectable with a clear margin. Radiotherapy again Mots on pr\trtbto Figure 1 . Fate of patients with carcinoma of the oesophagus (Pearson 1977) seems unsuitable, since many patients will die of distant metastases. In carcinoma of the oesophagus, for example ( Figure 1 ), radiotherapy might contribute towards the control of the primary tumour. However, of those who are apparently cured locally, two thirds will die within two years of distant metastases, malnutrition, intercurrent disease and old age.
A major change in this traditional way of approaching gastrointestinal tumours has resulted from new methods of diagnostic imaging, such as fibreoptic endoscopy, liver isotope scanning and, more recently, computerized axial tomography. Since tumours can often be diagnosed without laparotomy, it has been suggested that radiotherapy or chemotherapy should be given before rather than after surgery. Secondly, more information has become available on the reasons tumours recur following surgery.
Local penetration and regional lymph nodes For most gut carcinomas, the pathologist's report on the resected tumour and regional lymph nodes gives an accurate guide to both prognosis and the probability of local recurrence (Union Internationale Contre le Cancer 1978). There is certainly conflicting evidence as to the need for extensive surgery and it may be that early cases could be cu'red by conservative procedures, whilst advance cases will recur whatever the operation performed (Dupont et al. 1978 , Higgins 1977 , Nicholls et al. 1979 , Gilbertsen 1959 . However, radical operations will always provide the information needed to select cases which require adjuvant chemotherapy or radiotherapy.
'Second look' operation The pattern of recurrence following surgery is of particular interest to the radiotherapist, since his treatment beam can only affect those areas to which it is directed. Information from clinical and post-mortem studies has repeatedly suggested that local recurrence following surgery may occur without distant metastases, particularly in carcinoma of the stomach (Iwanaga et al. 1978 ) and rectum (Morson et al. 1963) . Detailed information has been reported from Salt Lake City on a policy of reoperation or 'second look' surgery following curative resection of these two tumours (Gunderson & Sosin 1974 . In these series, local recurrence occurred in isolation in roughly half the cases. Although it is not clear whether control of local recurrence will affect survival to any extent, radiotherapy is used for this purpose for tumours in other sites, such as carcinoma of the breast. This is justified since local recurrence is considered a particularly unpleasant way of dying.
Radiotherapy for gut carcinoma Radiosensitivity ofgut carcinoma It has been known for some years that large tumours arising from the rectum or oesophagus will shrink following radiotherapy. Although the majority of these will regrow, a few are permanently cured (Williams & Horwitz 1956 , Pearson 1977 . It has also been shown that radiotherapy can cure early carcinoma of the rectum (Papillon 1975) . More recently, radiotherapy has been given immediately before surgery for rectal carcinoma. In most cases there has been a reduction in the apparent volume of tumour both at the primary site and in the regional lymph nodes (Stevens et al. 1976 , Kligerman et al. 1972 .
There is, therefore, no evidence that adenocarcinomas arising from the alimentary tract are completely resistant to radiation. However, it has been shown that the speed at which these tumours shrink is very variable. This component of the response to radiotherapy is probably not determined by the number of viable tumour cells, most of which are, sterilized by a few fractions of radiation (Suit et al. 1965) . It does, however, seem to correlate with the original growth rate, in that rapidly growing tumours shrink fastest following radiation (Breuer 1966 ). Tumours may not be completely sterilized by radiation if they are both large and slowly growing. For various reasons the majority of gastrointestinal tract carcinomas are of considerable size when diagnosed. Material at their core is likely to be poorly vascularized and therefore resistant to radiation. Furthermore, they appear to grow very slowly (Welin et al. 1963 ). However, there is a wide spectrum of growth rates and this may explain variations in Time Tine
Operation-Recurrence
Recurrence-Death Figure 2 . Histogram of survival times of 32 patients with rectal cancerwhodeveloped local recurren'ce at varying times following resection. All patients were given palliative radiotherapy at Christie Hospital, Manchester. There is no relation between dose of radiation and survival, but a strong correlation (Spearman's rho=0.38, P<0.03) between intervals before and after recurrence survival rates (Figure 2 ). It is also likely to influence the curability of individual tumours by a fixed dose of radiation. The dose is fixed by the tolerance of surrounding normal tissues to radiation. Any increase in dose should be accompanied by some attempt to exclude these tissues from the radiotherapy field.
Damage to normal tissues
In recent years considerable advances have been made in excluding uninvolved structures from the high dose of radiation aimed at the primary tumour. The net result has been an increase in the effective dose which can be delivered with safety. Megavoltage radiotherapy machines treat small, well-defined volumes at depth to a homogenous dose, in 'a way which was impossible with orthovoltage equipment. Organs of interest such as the kidney, spinal cord and liver can now be localized accurately in each patient using computerized axial tomography so that the entry and exit beams can be positioned to avoid them. Survival rates in Hodgkin's disease and in testicular tumours have improved largely as a result of these technical developments in radiotherapy machinery. The small bowel has now become the major obstacle to a further increase in radiotherapy dose to the abdomen and pelvis. 'Radiation damage to the small bowel in the pelvis has occurred following radiotherapy for carcinoma of the bladder, prostate and uterus (Galland & Spencer 1979 , Cram et at. 1977 . Using barium studies, Green et at. (1975) have shown that a variety of manoeuvres can be used to move the -bowel out of the radiotherapy field; these include changing the patient's position and keeping the bladder distended.
When normal tissues are subjected to the combined injury of surgery and radiotherapy, they are more likely to suffer damage. Following surgery, loops of bowel are often tethered in the radiotherapy field by fibrosis. Following radiotherapy, progressive fibrosis ofconnective tissue and small blood vessels may de'lay or prevent surgical healing. If radical radiotherapy is combined with radical surgery, morbidity due to the breakdown of normal tissues is therefore likely to in'crease. Radiotherapy doses for carcinoma ofcervix uteri are generally reduced from radical levels if sur-gery is planned or has been completed. Those patients traditionally considered -a poor surgical risk, such as the obese, the elderly, diabetics and'hypertensives, tolerate radiotherapy less well, and in such cases the dose should also be reduced.
Radiotherapy combined with surgery Radiotherapy has been combined with surgery largely to prevent local recurrence of tumour some time following operation. Radiotherapy can have no effect on metastases which are present but undetected at the time of operation. If death is due mainly to local recurrence, the addition of radiotherapy to conventional surgery might be expected to increase survival.
The most accurate way of assessing the benefit of radiotherapy, however, is to detect a decrease in local recurrence rates. For obvious reasons this is difficult with gastrointestinal tumours. Published reports of combined treatment mention radiotherapy fields of various sizes. It is not clear at present whether local recurrence arises from deposits in regional nodes or in organs adjacent to the line of resection. Small radiotherapy fields are not designed to sterilize regional lymph nodes.
Radiotherapy may be given immediately before or immediately after radical surgery. The advantage of the latter method is that early cases can be identified using the pathologist's report and excluded from additional treatment. Clips can be placed in the operation bed to direct radiotherapy fields more accurately.
Preoperative radiotherapy has the advantage of shrinking tumours so that resections are technically easier, although it is now clear that the rate at which adenocarcinomas regress is very variable. It has also been suggested that preoperative radiotherapy may reduce metastases produced by surgical manipulation.
Whenever radiotherapy has been combined with surgery for carcinoma of the oesophagus and pancreas, there has been little improvement in survival (Pearson 1977 , Dobelbower 1979 . Information regarding local recurrence rates is not generally reported.
In carcinoma of the rectum, however, it is clear that pelvic recurrence following surgery is markedly reduced by both preoperative and postoperative radiotherapy (Kligerman et al. 1972 , Stevens et al. 1976 , Turner et al. 1977 , Romsdahl & Withers 1978 . Three separate studies have shown an improvement in 5-year survival rates in the irradiated compared with the unirradiated group. This difference becomes more impressive as the preoperative dose of radiation is increased from 500 rad (Rider 1975 ) through 2000 rad (Roswit et al. 1975) to 5000 rad (Stevens et al. 1978 ).
Conclusions
Survival rates It is unlikely that radiotherapy will improve survival rates in carcinoma of the oesophagus and pancreas, since survival is determined by factors beyond the control of surgeon or radiotherapist. It is not surprising, therefore, that identical figures are achieved by radical radiotherapy or radical surgery (Pearson 1977 , Dobelbower 1979 . It could be argued that until drugs are developed to control distant metastases, patients should be offered the radical treatment carrying least morbidity, namely radiotherapy.
In contrast, it has been shown that for carcinoma of the colon, rectum and stomach, distant metastases are less frequent. In colorectal carcinoma, radiotherapy has been shown to cure early tumours, convert unresectable into resectable cases and reduce pelvic recurrence following surgery. It has an established place in relieving symptoms due to pelvic recurrence, and should be considered more often as a radical treatment for patients who are unfit for major surgery because of age or medical problems.
Two important questions have yet to be answered. First, can more cases of rectal or stomach cancer be cured by radiotherapy alone? The aim here would be to avoid the morbidity and mortality of radical surgery. Secondly, which cases might benefit from a combination of radiotherapy and surgery designed to reduce local recurrence? It should be remembered that survival rates would not necessarily improve in either case.
Clinical staging
There is little doubt that advanced cases will continue to require something more than radiotherapy alone in order to control the bulk of local disease. The problem is how to distinguish early from advanced cases without the benefit of laparotomy and pathological staging. A solution should be forthcoming given close cooperation between surgeons, radiotherapists and diagnostic radiologists. What is needed is more information on the reliability of current selection methods. The logical way of obtaining this information is by linking clinical selection with pathological staging which becomes available following resection. It should be remembered that pathological staging is altered to some extent by preoperative radiotherapy.
Morbidity and local recurrence Information is also required on the radiosensitivity of gastrointestinal carcinomas compared with normal tissues such as the small bowel. Healing of anastomoses could be delayed or compromised by preoperative irradiation. This sort of information can only be derived from clinical studies. The dose of radiation and arrangement of fields should obviously be recorded. Every effort should be made to develop a noninvasive method of determining local recurrence, since this is the only reliable method of determining the value of radiotherapy.
Finally, it should be remembered that the aim of all these studies is to spare at least some patients the morbidity of surgery without compromising their chances of survival, or substituting an unacceptable level of radiation damage.
